HDL-Based Therapy: Vascular Protection at All Stages

Area of Science:

• Biochemistry
• Pathology
• Pharmacology

Background:

• Lipid metabolism disorders are implicated in diverse pathologies, including cardiovascular, metabolic, neurodegenerative diseases, and cancer.
• These conditions present complex pathogenesis, complicating diagnosis and treatment.
• High-density lipoprotein (HDL) plays a crucial role in lipid metabolism, notably in reverse cholesterol transport and vascular protection.

Purpose of the Study:

• To review current and emerging high-density lipoprotein (HDL)-based therapeutic strategies.
• To explore the role of HDL in various pathologies and its potential as a therapeutic target.

Main Methods:

• Literature review of studies investigating HDL function in disease.
• Analysis of HDL-based therapeutic approaches in preclinical and clinical development.
• Examination of the correlation between HDL cholesterol levels and cardiovascular risk.

Main Results:

• HDL exhibits protective functions in conditions such as Alzheimer's disease and atherosclerosis.
• Serum HDL cholesterol levels negatively correlate with cardiovascular risk.
• HDL-C presents a promising target for therapeutic interventions.

Conclusions:

• HDL-based therapies offer a promising avenue for managing diseases linked to lipid metabolism disorders.
• Further research into HDL's multifaceted roles can unlock novel treatment strategies.
• Targeting HDL may mitigate risks associated with cardiovascular and other related diseases.